Sander Veldhuyzen Van Zanten
Overview
Explore the profile of Sander Veldhuyzen Van Zanten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1806
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma S, Stewart M, Mathias H, Novak K, Veldhuyzen Van Zanten S, Heisler C, et al.
PLoS One
. 2024 Dec;
19(12):e0313201.
PMID: 39739887
Background: Primary healthcare providers play a critical role in diagnosing and managing digestive disorders. Standardized clinical care guidelines have been developed, but with limited and inconsistent implementation. An evidence-based gastroenterology...
2.
Novak K, Qureshi A, Carter J, Mazurek M, Belletrutti P, Maracle B, et al.
Can Fam Physician
. 2024 Dec;
70(11-12):e197-e206.
PMID: 39638385
Objective: To evaluate health system use, health outcomes, and avoided costs when patients with chronic gastrointestinal (GI) conditions are managed in the medical home. Design: A retrospective, observational cohort study...
3.
Yang D, Bowron J, Ahmed M, Abraldes J, Veldhuyzen Van Zanten S
J Can Assoc Gastroenterol
. 2024 Oct;
7(5):346-351.
PMID: 39416719
Background: Computed tomography of the head (CT head) is frequently used for patients with cirrhosis presenting with suspected hepatic encephalopathy (HE). Aims: The primary aims of this study were to...
4.
Veldhuyzen Van Zanten S, Kuipers E
Ann Intern Med
. 2024 Sep;
177(9):JC107.
PMID: 39222515
Imperiale TF, Porter K, Zella J, et al; BLUE-C Study Investigators. N Engl J Med. 2024;390:984-993. 38477986.
5.
Veldhuyzen Van Zanten S
Ann Intern Med
. 2024 Jul;
177(7):JC76.
PMID: 38950390
Zhuang Q, Chen S, Zhou X, et al. Am J Gastroenterol. 2024;119:803-813. 38345252.
6.
Krahn T, Buttenschoen J, DSouza P, Girgis S, Thiesen A, Rennie R, et al.
J Can Assoc Gastroenterol
. 2024 Jun;
7(3):221-229.
PMID: 38841147
Background: Updated 2016 consensus guidelines recommend treatment for 14 days with concomitant therapy (proton-pump inhibitor (PPI)-amoxicillin-metronidazole-clarithromycin (PAMC) or bismuth-based quadruple therapy (PPI-bismuth-metronidazole-tetracycline, PBMT)) as first line, PBMT or PPI-amoxicillin-levofloxacin (PAL)...
7.
Maracle B, Crick K, Novak K, Campbell-Scherer D, Veldhuyzen Van Zanten S, Sadowski D
J Can Assoc Gastroenterol
. 2024 Jun;
7(3):230-237.
PMID: 38841145
Background: Dyspepsia is a common, generally low-risk gastrointestinal condition. The American College of Gastroenterology and Canadian Association of Gastroenterology recommend avoiding gastroscopy in healthy patients <60 years old. Many dyspeptic...
8.
Veldhuyzen Van Zanten S, Ritchie B
Ann Intern Med
. 2024 Feb;
177(2):JC22.
PMID: 38315999
Alexander M, Harris S, Underhill C, et al. JAMA Oncol. 2023;9:1536-1545. 37733336.
9.
Barber T, Crick K, Toon L, Tate J, Kelm K, Novak K, et al.
J Can Assoc Gastroenterol
. 2023 Dec;
6(6):234-243.
PMID: 38106487
Background: Gastroscopy to investigate dyspepsia without alarm symptoms rarely results in clinically actionable findings or sustained health-related quality-of-life improvements among patients aged 18-60 years and is, therefore, not recommended. Despite...
10.
Wang T, Girgis S, Chang H, Assi A, Fagan-Garcia K, Cromarty T, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568765
Community-driven projects have characterized () infection in Indigenous communities in the Northwest Territories (NT) and Yukon (YT), Canada. These projects address concerns about the frequent diagnosis of infection among community...